Authors: First, MR Weiskittel, P Burton, ML Shah, MB Dreyer, D Fleck, P Bey, C Peddi, VR Canafax, DM Schroeder, TJ

Citation: Mr. First et al., Nine-month follow-up of SangCya (Sang-35) in kidney transplant patients after conversion from Sandimmune, TRANSPLAN P, 31(1-2), 1999, pp. 324-325

Authors: Peddi, VR Schroeder, TJ Weiskittel, P First, MR

Citation: Vr. Peddi et al., Graft outcome in patients with biopsy-proven chronic renal allograft rejection, TRANSPLAN P, 31(1-2), 1999, pp. 1308-1309

Authors: First, MR Weiskittel, P Shah, M Peddi, VR Canafax, D Schroeder, TJ

Citation: Mr. First et al., Conversion of stable renal transplant recipients from sandimmune to sang-35, a neoral-equivalent cyclosporine formulation, using a dose-adjusted method, TRANSPLAN P, 30(8), 1998, pp. 3955-3957

Authors: Daoud, AJ Schroeder, TJ Shah, M Hariharan, S Peddi, VR Weiskittel, P First, MR

Citation: Aj. Daoud et al., A comparison of the safety and efficacy of mycophenolate mofetil, prednisone and cyclosporine and mycophenolate mofetil, and prednisone and tacrolimus, TRANSPLAN P, 30(8), 1998, pp. 4079-4081